Our data showing no radiosensitivity differences between EGFR mutant and wild-type groups at high doses (i.e., SF8 and SF6) suggest that hypofractionated irradiation employing high fraction size is likely to achieve comparable tumor control regardless of EGFR status. This evidence concerns the gene EGFR and neoplasm.